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Introduction
Munc18-1 is an essential component of the molecular machin-
ery that controls SNA RE-mediated membrane fusion in neu-
rons and neuroendocrine cells. It acts by transporting a SNA RE 
protein called syntaxin1A to the plasma membrane (Han et al., 
2009; Malintan et al., 2009; Martin et al., 2013; Papadopulos et 
al., 2013) and by regulating the formation of the SNA RE com-
plex during synaptic vesicle priming, a process that drives the 
fusion of synaptic vesicles, thereby mediating neurotransmit-
ter release at the synapse. A milestone study demonstrated that 
Munc18-1 knockout leads to perinatal paralysis-induced lethal-
ity but, importantly, does not affect brain development (Verhage 
et al., 2000). Recently, however, Munc18-1 heterozygous muta-
tions have been associated with several developmental diseases, 
including nonsyndromic intellectual disability, epilepsy (Ham-
dan et al., 2009, 2011; Deprez et al., 2010; Otsuka et al., 2010; 
Mignot et al., 2011), and early infantile epileptic encephalopa-
thy (EIEE; Saitsu et al., 2008, 2010). EIEEs comprise a group 
of rare but severe developmental disorders, with a poor initial 
prognosis (50% of patients die within the first year; Tavyev 
Asher and Scaglia, 2012; Barcia et al., 2014). Munc18-1 mu-
tations linked to the development of EIEE4 include intragenic 
and whole-gene deletions, as well as 10 different missense 
mutations (Saitsu et al., 2008, 2010; Otsuka et al., 2010). The 
mechanism by which these mutations lead to the pathological 
epileptic phenotype is poorly understood and may involve ei-
ther haploinsufficiency of the wild-type (WT) protein or a gain 
of pathological function of the mutant allele. In addition, dys-
regulation of Munc18-1 expression has been associated with 
other neurological disorders, including Alzheimer’s disease 
(Jacobs et al., 2006; Donovan et al., 2012) and Rasmussen en-
cephalitis (Alvarez-Barón et al., 2008). In this study, we reveal 
a critical new role for Munc18-1 in chaperoning α-synuclein (α-
Syn), thereby controlling its aggregative propensity and ability 
to form toxic α-Syn oligomers.
Results
The Munc18-1C180Y mutation induces 
coaggregation of Munc18-1WT in a cell-
free system
In a recent study, we demonstrated that expression of Munc18-1 
carrying the missense EIEE4-causing mutation (C180Y; 
Fig.  1  A) leads to its cellular aggregation, with catastrophic 
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effects on neuroexocytosis (Martin et al., 2014). The mutation 
promotes misfolding and aggregation, potentiating the protein’s 
ubiquitination and degradation by the proteasome, thereby 
inhibiting its availability for membrane fusion (Saitsu et al., 
2008; Martin et al., 2014). We also examined the process of 
Munc18-1C180Y aggregation using single-molecule fluorescence 
spectroscopy to directly assess oligomerization of fluorescently 
tagged Munc18-1WT and Munc18-1C180Y expressed in a eukary-
otic-cell-free system (Martin et al., 2014). These experiments 
revealed the existence of large aggregates of Munc18-1C180Y, as 
indicated by the detection of bright particles, detected as large 
fluctuations in fluorescence intensity that were never observed 
for Munc18-1WT molecules (Martin et al., 2014). As widespread 
aggregation was observed in Munc18-1C180Y-expressing cells, 
we questioned whether these could contribute to a dominant 
pathological function by incorporating the WT Munc18-1 pro-
tein. We first performed two-color coexpression experiments 
and examined the ability of the Munc18-1C180Y mutant to incor-
porate Munc18-1WT proteins into large aggregates by two-color 
single-molecule detection (Martin et al., 2014; Fig.  1, B–E). 
We observed that the C180Y mutant and WT proteins indeed 
coaggregated (Fig. 1 D). Coincidental detection of the two la-
bels was widespread (Fig. 1 E), confirming the incorporation of 
Munc18-1WT in most Munc18-1C180Y aggregates.
Importantly, in coexpression experiments in vitro, we 
did not observe a random aggregation process (identified by 
frequent fluorescence bursts with widely varying size distribu-
tions) but rather detected relatively rare and very large bursts 
of fluorescence intensity (Fig. 1 D). This suggested an ordered 
self-association and the formation of polymer-like structures 
that extend by recruitment of monomers. In this scenario, once 
a small aggregate is formed, this “seed” can recruit new pro-
teins and elongate/grow to form larger fibrils. To test the po-
tential formation of self-propagating aggregates, we performed 
two-color experiments incorporating preformed seeds of aggre-
gated Munc18-1C180Y (Fig. 1, F–H). Munc18-1C180Y tagged with 
mCherry was first expressed separately, purified by centrifu-
gation and fragmented by sonication (Fig. 1 F). These “seeds” 
were added to a solution of purely monomeric Munc18-1C180Y 
tagged with GFP. Within a few minutes, we detected the po-
lymerization of Munc18-1C180Y-GFP triggered by the Munc18-
1C180Y-mCherry “seeds,” indicating self-replication properties. 
Most interestingly, we also detected a similar recruitment of 
Munc18-1WT monomers to Munc18-1C180Y seeds (Fig.  1  G), 
suggesting that Munc18-1C180Y can convert Munc18-1WT into 
an aggregative form. Coincidental detection of the two labels 
also confirmed incorporation of Munc18-1WT in most Munc18-
1C180Y aggregates (see Fig.  1  H for individual bursts and 
Fig. 1 I for quantification of recruitment of the Munc18-1WT on 
the Munc18-1C180Y seeds).
Munc18-1 EIEE4-causing mutations 
coaggregate Munc18-1WT and form Lewy 
body–like structures
We next examined Munc18-1 aggregative behavior in cells. 
We first engineered gene-edited PC12 cells lacking Munc18-1 
using the clustered regularly interspaced short palindromic re-
peats/Cas9 (CRI SPR-Cas9) system (Fig.  2  A and Fig. S1 A) 
in order to perform dual-expression experiments mimicking 
the heterozygous nature of EIEE4 disorders. Western blotting 
of Munc18-1 knockout (MKO) PC12 cells revealed no ex-
pression of endogenous Munc18-1 (Fig.  2  B). Furthermore, 
neuroexocytosis in these cells was significantly compromised, 
and this was restored to normal levels by Munc18-1WT over-
expression (Malintan et al., 2009; Fig. S1, B and C). We also 
checked the level of overexpression, which was slightly higher 
than that of endogenous Munc18-1 in PC12 cells (Fig. S1 D). 
After coexpression of Munc18-1WT-emGFP and Munc18-1WT-
mCherry, no fluorescent aggregates could be detected in either 
the green or the red channel (Fig. 2 C). As expected, large co-
aggregates could be detected upon coexpression of Munc18-
1C180Y-emGFP and Munc18-1C180Y-mCherry. Most interestingly, 
similar coaggregates were observed in MKO-PC12 cells coex-
pressing Munc18-1WT-emGFP and Munc18-1C180Y-mCherry 
(Fig. 2, D and E). Switching tags led to the same coaggregative 
phenotype (Fig. S2 A), and an identical outcome was observed 
in PC12 cells (Fig. S2, B and C) and rat hippocampal neurons 
(Fig. 2, F–H; and Fig. S2 A). Importantly, we tested three other 
EIEE4-causing mutations selected from each of the known do-
mains of Munc18-1 (Fig. 3, A and B) and found that they also 
possessed the ability to aggregate Munc18-1WT (Fig. 3, C and D).
Our results (Figs. 2 and 3) demonstrate that EIEE4-causing 
Munc18-1 mutations trigger the coaggregation of Munc18-1WT 
in neurons and neurosecretory cells. This raises the possibil-
ity that the aggregation could deplete the pool of functional 
Munc18-1WT in vivo or have additional pathological func-
tions such as those seen in Lewy body dementia (Spillantini 
et al., 1997; Galvin et al., 1999; Maries et al., 2003) that could 
contribute to the pathological phenotype of EIEE. In support 
of this view, we occasionally noticed the formation of struc-
tures that were morphologically reminiscent of Lewy bodies 
in MKO-PC12 cells expressing Munc18-1C180Y-emGFP (Fig. 
S3 A) or coexpressing Munc18-1C180Y-emGFP and Munc18-
1WT-mCherry (Fig. S3 B).
The Munc18-1C180Y mutation induces the 
coaggregation of α-Syn in a cell-free system
As α-Syn is a key component of Lewy bodies (Polymero-
poulos et al., 1997; Burré et al., 2014), we hypothesized that 
EIEE4-causing Munc18-1 mutations could promote coaggrega-
tion of other proteins prone to aggregation such as α-Syn. We 
therefore investigated whether Munc18-1C180Y was capable of 
aggregating α-Syn or other proteins involved in neuronal traf-
ficking, such as SNAP25 (Polymeropoulos et al., 1997; Burré et 
al., 2014). As a control, SOD1, a protein linked to familial amy-
otrophic lateral sclerosis, was included in the coaggregation 
analysis. Recent studies have shown that SOD1 has an aggrega-
tive behavior (Wang et al., 2009; Lang et al., 2015). Upon coex-
pression of Munc18-1C180Y-GFP with α-Syn-mCherry in vitro, 
we found that α-Syn was indeed incorporated into Munc18-
1C180Y oligomers (Fig. 4, A and B). This effect was specific as 
neither SNAP25 (Fig. 4, C and D) nor SOD1 (Fig. 4, E and F) 
showed similar coaggregation behavior.
Munc18-1C180Y mutation induces the 
aggregation of α-Syn and the formation of 
Lewy body–like structures
We next investigated whether Munc18-1C180Y was also ca-
pable of promoting α-Syn aggregation in PC12 cells and 
neurons. Upon coexpression of Munc18-1WT-emGFP and 
α-Syn-mCherry in PC12 cells, no fluorescent aggregates were 
detected in either the green or red channel (Fig. 5 A). However, 
coexpression of Munc18-1C180Y-emGFP and α-Syn-mCherry 
generated many aggregates nearly all of which were α-Syn 
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Figure 1. Munc18-1C180Y induces the coaggregation of Munc18-1WT in vitro. (A) Structural representation of Munc18-1C180Y. (B) Principle of the coexpres-
sion assay. Munc18-1C180Y tagged with mCherry is coexpressed with a GFP-tagged Munc18-1WT. (C) Schematic representation of single-molecule fluores-
cence experiment in which the proteins freely diffuse in and out of the focal volume created by two lasers simultaneously exciting the GFP and mCherry 
fluorophores. (D) A single-molecule trace obtained for lysates coexpressing Munc18-1WT-emGFP and Munc18-1C180Y-mCherry. The number of photons 
detected in the green and red channels are plotted as a function of time. The trace shows a simultaneous burst in both the GFP and mCherry channels that 
reflects the formation of complexes containing both fluorophores. (E) Histogram of single-molecule coincidence between Munc18-1WT-emGFP and Munc18-
1C180Y-mCherry coexpressed in a cell-free system. The coincidence is calculated as the ratio of intensity in the mCherry channel divided by the sum of signals 
in the GFP and mCherry channels. GFP-only bursts show a coincidence at 0, and mCherry-only oligomers are located at coincidence equal to 1. For the 
oligomers containing both fluorophores, the coincidence ratio is a measure of the stoichiometry of the assembly. More than 50 individual aggregates were 
analyzed for the histogram, for a total of 2,600 time points above threshold. (F) Principle of a seeding experiment. Munc18-1C180Y-mCherry is expressed 
in the L. tarentolae extracts, and fibrils are formed. After expression, the sample is spun down, and the aggregates are collected and sonicated to give 
smaller seeds visible in the mCherry channel. Those seeds are mixed into a solution of Munc18-1WT-emGFP. (G) A single-molecule trace obtained from 
seeding experiments. Munc18-1WT-GFP is recruited to the seeds of Munc18-1C180Y-mCherry (H) Details of individual bursts representing different aggregates 
diffusing through the focal volume, clearly showing codiffusion of the two fluorophores. (I) Histogram of single-molecule coincidence between Munc18-
1WT-GFP and seeds of Munc18-1C180Y-mCherry. The recruitment of GFP onto the mCherry-labeled seeds was calculated from 88 individual aggregates, 
representing 3,789 time points.
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Figure 2. Munc18-1C180Y mutation coaggregates Munc18-1WT in Munc18-1 knockout PC12 cells and hippocampal neurons. (A) Schematic diagram of the sgRNA 
target site. The 20-nt guide sequence comprising the 5′-end of the chimeric single guide RNA (sgRNA) is shown. This sequence pairs with the DNA target site 
(indicated on the bottom strand). Immediately 3′ to the target sequence is the trinucleotide protospacer adjacent motif (PAM; 5′-NGG). The CAS9 enzyme mediates 
a double-stranded break (DSB) ∼3 bp upstream of the PAM. (B) Cell lysates of WT (PC12 cells) and clonal Munc18-1 knockout isolates (MKO-PC12 cells) were 
subjected to Western blot analysis and probed with anti–Munc18-1 (red). A parallel set of lysates was probed with anti–actin antibody as a loading control (green). 
(C) Representative images showing coaggregates positive for Munc18-1C180Y and Munc18-1WT in MKO-PC12 cells. MKO-PC12 cells were cotransfected with 
Munc18-1WT-emGFP and Munc18-1WT-mCherry (top), Munc18-1C180Y-emGFP and Munc18-1C180Y-mCherry (middle), or Munc18-1WT-emGFP and Munc18-1C180Y-
mCherry (bottom). Bar, 20 µm. Arrowheads indicate colocalized aggregates. (D and E) Percentage of colocalized aggregates per cell and percentage of MKO-PC12 
cells containing aggregates. Data represent mean ± SEM; 10–20 cells were analyzed for each independent experiment (n = 7). (F) Representative images show-
ing coaggregates positive for Munc18-1C180Y and Munc18-1WT in hippocampal neurons. Hippocampal neurons (8 d in vitro) were transiently cotransfected with 
Munc18-1WT-emGFP and Munc18-1WT-mCherry or Munc18-1C180Y-emGFP and Munc18-1C180Y-mCherry or Munc18-1WT-emGFP and Munc18-1 C180Y-mCherry. Bar, 
20 µm. Percentage of colocalized aggregates per neuron (G) and percentage of hippocampal neurons containing aggregates (H). Data represent mean ± SEM; 
10–20 neurons were analyzed for each independent experiment (n = 6). Arrowheads indicate the colocalized aggregates.
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positive (Fig.  5  A). More than 80% of the Munc18-1C180Y– 
positive aggregates colocalized with α-Syn (Fig. 5 B), and the 
area occupied by α-Syn–positive aggregates was significantly 
increased upon Munc18-1C180Y-emGFP coexpression (Fig. 5 C). 
We also observed the presence of Lewy body–like structures 
upon expression of Munc18-1C180Y-emGFP and α-Syn-mCherry 
in MKO-PC12 cells (Fig. S3 C), and similar coaggregation was 
observed in hippocampal neurons (Fig. 5, D–F).
The specific recruitment of α-Syn to Munc18-1 mutant 
aggregates suggested that the proteins may also interact under 
nonpathological situations. We tested this using a pull-down 
strategy in PC12 cells expressing either Munc18-1C180Y-emGFP 
or Munc18-1WT-emGFP with α-Syn-mCherry. Both Munc18-
1WT and Munc18-1C180Y were immunoprecipitated to the same 
extent as the GFP-trap beads (Fig. 5 G). Under these conditions, 
we observed an interaction between Munc18-1WT and α-Syn, 
although we found that Munc18-1C180Y was able to pull down 
threefold more α-Syn than Munc18-1WT (Fig. 5 H). This sug-
gests that the native Munc18-1 and α-Syn proteins are able to 
interact with each other but that the aggregation of the Munc18-
1C180Y mutant then sequesters more α-Syn as it oligomerizes. 
Importantly, expression of Munc18-1C180Y-emGFP, as well as 
several other EIEE4-linked Munc18-1 mutants, also recruited 
endogenous α-Syn to these structures (Figs. 6, A–C). Similarly, 
expression of Munc18-1C180Y-emGFP in hippocampal neurons 
led to the aggregation of endogenous α-Syn and the formation 
of Lewy body–like structures (Fig. 7, A and B). We used correl-
ative fluorescence electron microscopy to further investigate the 
ultrastructure of these large aggregates in MKO-PC12 cells and 
found relatively disorganized electron-dense protein aggregates 
(Fig.  7  C). More interestingly, we noted that the expression 
of Munc18-1C180Y-emGFP in hippocampal neuron produced a 
much higher proportion of pyknotic nuclei compared with neu-
rons expressing Munc18-1WT-emGFP, demonstrating that these 
cells were indeed undergoing or about to undergo cell death 
(Fig.  7, D and E). Moreover, neurites from these Munc18-
1C180Y-emGFP–expressing neurons exhibited classical signs 
of neurodegeneration, including the presence of spheroids 
(Fig. 7 D) that are inherent to degenerative neurons conditions 
such as Alzheimer’s disease (Orimo et al., 2008). Munc18-
1C180Y-emGFP is therefore sufficient to confer a neurodegenera-
tive phenotype leading to neuronal cell death (Fig. 7, D and E).
Parkinson’s disease–linked α-Syn 
mutants coaggregate Munc18-1WT and 
endogenous Munc18-1
These experiments raised the question of whether the reverse 
scenario was possible: Would expression of a human mutation 
of α-Syn linked to Parkinson’s disease (PD) also lead to coaggre-
gation of Munc18-1WT? Coexpression of either α-SynA53T-GFP 
or α-SynA30P-GFP aggregation-prone mutants with Munc18-
1WT-mCherry in MKO-PC12 cells induced a clear aggregation 
Figure 3. Munc18-1 EIEE4-causing mutations 
coaggregate Munc18-1WT in MKO-PC12 cells. 
(A) Positions of missense mutations (V84D, 
M443R, and G544D) in the Munc18-1 
crystal structure are shown as a stereo rep-
resentation. (B) Schematic domain diagram 
of EIEE4-causing Munc18-1 mutations. (C) 
Representative images showing coaggre-
gates positive for Munc18-1V84D-emGFP and 
Munc18-1WT-mCherry (top), Munc18-1M443R-
emGFP and Munc18-1WT-mCherry (middle), 
or Munc18-1G544D-emGFP and Munc18-1WT-
mCherry (bottom) are shown. Bar, 20 µm. 
(D) Percentage of colocalized aggregates 
per cell. Data represent mean ± SEM; 15–20 
cells in each independent experiment were 
measured; n = 5.  Arrowheads indicate the 
colocalized aggregates.
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of Munc18-1WT-mCherry that colocalized with α-Syn mutant 
GFP-positive structures (Fig. 8, A–C). We also observed Lewy 
body–like structures in these cells (Fig. S4 A). Importantly, ex-
pression of either α-SynA53T-GFP or α-SynA30P-GFP was able 
to recruit endogenous Munc18-1 (Fig. 8, D–F) to form Lewy 
body–like structures in PC12 cells (Fig. S4 B). We also per-
formed coimmunoprecipitation from solubilized cortical neu-
rons and found that endogenous Munc18-1 strongly interacted 
with endogenous α-Syn (Fig. S5 A). Moreover, when Munc18-
1WT-emGFP and Munc18-1C180Y-emGFP were expressed in 
PC12 cells, we could detect the interaction of Munc18-1 and 
endogenous α-Syn (Fig. S5 B).
Munc18-1C180Y-emGFP oligomers in vitro can seed the 
oligomerization of Munc18-1WT-mCherry (Fig.  1, F–H), sug-
gestive aggregative properties. However, the same seeds were 
not able to induce the incorporation of α-Syn in vitro (Fig. 9, 
A and B); hence, the coaggregation of Munc18-1 and α-Syn in 
cells is likely driven during coexpression.
Munc18-1 acts as a chaperone for α-Syn 
and controls its aggregative propensity
Some of the EIEE4 disease-causing genetic alterations include 
partial or full deletion of Munc18-1 gene, suggesting that hap-
loinsufficiency is sufficient to generate a gain of pathological 
function. We hypothesized that Munc18-1 acts as a chaperone 
for α-Syn and that knocking out Munc18-1 should be suffi-
cient to alter the propensity of α-Syn to aggregate. To test our 
hypothesis, we first examined the ability of Munc18-1 to re-
duce α-SynA30P oligomer formation in vitro. In support of the 
chaperone hypothesis, coexpression of Munc18-1 drastically 
reduced the propensity of α-Syn mutants to form large poly-
mers in single-molecule fluorescence analysis (Fig.  9, C–E). 
We next investigated whether the level of Munc18-1 affected 
the aggregation of endogenous α-Syn in neurosecretory cells 
by comparing the number of α-Syn aggregates in PC12 cells 
and MKO-PC12 cells. This analysis revealed that knocking 
out Munc18-1 significantly increased the number of α-Syn ag-
gregates (Fig. 9 F). Importantly, reexpression of Munc18-1 in 
MKO-PC12 cells significantly reduced these aggregates in a 
dose-dependent manner (Fig. 9, F–I).
Finally, we compared the number of aggregates formed 
in MKO-PC12 cells and PC12 cells expressing α-SynWT and 
mutants. We found that the number of α-SynWT aggregates was 
significantly higher in MKO-PC12 cells than in PC12 cells 
(Fig. 10). In addition, MKO-PC12 cells expressing α-Syn mu-
tants (A30P and A53T) also exhibited significantly more aggre-
gates than PC12 cells. Importantly, Munc18-1 reexpression in 
MKO-PC12 cells was sufficient to rescue the number of α-Syn 
aggregates back to the level detected in PC12 cells (Fig.  10, 
A–C). Our results therefore suggest that Munc18-1 plays a key 
role in chaperoning α-Syn and that Munc18-1 haploinsuffi-
ciency is sufficient to promote the aggregative phenotype.
Discussion
In this study, we used independent experimental approaches 
to show that Munc18-1 mutations leading to EIEE4 have 
Figure 4. Single-molecule coincidence mapping of interac-
tions between Munc18-1C180Y and α-Syn. (A) A single-mol-
ecule trace obtained for cell-free lysates coexpressing 
α-SynWT-mCherry and Munc18-1C180Y-GFP. The number of 
photons detected in the green and red channels are plotted 
as a function of time. The trace shows simultaneous bursts 
in the GFP and mCherry channels that reflect the formation 
of complexes containing both fluorophores. (B) Histogram of 
single-molecule coincidence between α-SynWT-mCherry and 
Munc18-1C180Y-GFP coexpressed in a cell-free system. Note 
that the Munc18-1C180Y aggregates are now located on the 
left off the histograms, and insertion of the α-SynWT pushes 
the distribution to higher stoichiometry values. (C) A sin-
gle-molecule trace obtained for a cell-free lysate coexpressing 
SNAP-25-GFP and Munc18-1C180Y-mCherry. The trace shows 
no simultaneous burst in the GFP and mCherry channels, sug-
gesting that SNAP-25 does not coaggregate with Munc18-
1C180Y (D) Histogram of single-molecule coincidence between 
SNAP-25-GFP and Munc18-1C180Y-mCherry. The diagram 
indicates that most mCherry-only oligomers are located at 
coincidence equal to 1. (E) Single-molecule coincidence be-
tween SOD1-GFP and Munc18-1C180Y-mCherry coexpressed 
in a cell-free lysate. (F) Histogram of single-molecule coinci-
dence between SOD1-GFP and Munc18-1C180Y-mCherry. The 
trace shows that there is no coaggregation between SOD1-
GFP and Munc18-1C180Y-mCherry. The data were analyzed 
based on >40 individual aggregates for each protein pair, 
representing >2,500 time points.
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the ability to coaggregate Munc18-1WT in vitro as well as in 
neurosecretory cells engineered to knock out Munc18-1 and 
in hippocampal neurons. The discovery of Lewy body–like 
structures that were positive for Munc18-1 prompted us to 
investigate a potential link between Munc18-1 and α-Syn, 
a hallmark of Lewy bodies in PD (Spillantini et al., 1997; 
McKeith, 2004). This led us to identify a novel interaction be-
tween native Munc18-1 and α-Syn proteins and demonstrate 
that Munc18-1 EIEE4-linked mutant aggregates incorporate 
α-Syn. Conversely, two mutants of PD-linked α-Syn also 
promoted Munc18-1 aggregation, suggesting an underlying 
overlap between the different neurological diseases that will 
require further exploration.
Finally, we provide the first evidence that knocking out 
Munc18-1 is sufficient to promote α-Syn aggregation. Further-
more, reexpression of Munc18-1WT can rescue this phenotype 
in a dose-dependent manner, suggesting that Munc18-1 haplo-
insufficiency and mutations lead to an aggregative phenotype. 
To the best of our knowledge, our study is the first to indicate 
a functional link between Munc18-1 and α-Syn with clear rel-
evance to pathologies caused by mutations of both molecules.
Munc18-1C180Y leads to α-Syn aggregation
We recently demonstrated that the Munc18-1C180Y human muta-
tion triggers widespread subcellular aggregation (Martin et al., 
2014), suggesting that Munc18-1 could also have intracellular 
aggregative activity. We observed that 30–40% of MKO-PC12 
cells expressing the EIEE mutants contain aggregates. This per-
centage is consistent with our previous findings in PC12 cells. It 
should be noted, however, that only 20% of N2a cells transfected 
with the same mutants give rise to large aggregates (Saitsu et al., 
2008). We can only assume that these subtle differences stem 
from the different cell lines used. One possibility is that the level 
of Munc18-1 mutant expression is lower in N2a cells, thereby 
reducing its propensity to aggregate. Indeed, the four different 
mutations lie buried within the hydrophobic core of domains 1, 2, 
and 3b, making the protein unstable and potentiating its degrada-
tion through the proteasome (Martin et al., 2014). Using single- 
molecule analysis, we first demonstrated that Munc18-1C180Y can 
self-propagate in vitro. Our results highlight a self-perpetuated 
aggregation of Munc18-1 mutants, suggesting the existence of 
a switch between the soluble and aggregated forms of the mu-
tant protein. The ability to template Munc18-1WT aggregation 
Figure 5. Munc18-1C180Y mutation induces 
the aggregation of α-Syn in PC12 cells and 
hippocampal neurons. (A) Representative 
images showing coaggregates positive for 
α-Syn and Munc18-1WT (top) and α-Syn and 
Munc18-1C180Y (bottom) in PC12 cells. Bars, 
20 µm. Arrowhead indicates the colocalized 
aggregate. PC12 cells were cotransfected with 
either α-Syn-mCherry and Munc18-1WT-emGFP 
or α-Syn-mCherry and Munc18-1C180Y-emGFP. 
(B) Percentage of colocalized aggregates. 
(C) Area occupied by α-Syn aggregates. A 
mean of 8–20 cells were analyzed for each 
independent experiment (n = 4; ***, P < 
0.001, unpaired Student’s t test). (D) Rep-
resentative images showing coaggregates 
positive for α-Syn and Munc18-1WT (top) and 
α-Syn and Munc18-1C180Y (bottom) in hip-
pocampal neurons. Hippocampal neurons 
were cotransfected either α-Syn-mCherry and 
Munc18-1WT-emGFP or α-Syn-mCherry and 
Munc18-1C180Y-emGFP at 8 d in vitro. Bars, 20 
µm. Arrowhead indicates the colocalized ag-
gregates. (E) Percentage of colocalized aggre-
gates. (F) Area occupied by α-Syn aggregates. 
10–15 neurons in each independent experi-
ment were analyzed (n = 5; ***, P < 0.001, 
unpaired Student’s t test). (G) PC12 cells were 
either cotransfected with Munc18-1WT-emGFP 
and α-Syn-mCherry or Munc18-1C180Y-emGFP 
and α-Syn-mCherry. They were lysed, solubi-
lized, and immunoprecipitated with anti-GFP 
antibodies. Western blot analysis was per-
formed using anti–α-Syn and anti–Munc18-1 
antibodies. (H) The interaction between α-Syn 
and Munc18-1 was quantified after normaliz-
ing against the amount of immunoprecipitated 
Munc18-1.  Data represent mean ± SEM of 
band intensities normalized to control values 
of Munc18-1WT (n = 3; ***, P < 0.001, un-
paired Student’s t test).
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implies that the mutant-altered conformation can also be reached 
by the WT, although the aggregation of the latter is unlikely to 
be thermodynamically favored under normal conditions. Hence, 
our results suggest a high level of selectivity in the coaggrega-
tion (Kim et al., 2013; Martin et al., 2014).
Interestingly, EIEE4-causing mutant aggregates of 
Munc18-1 acted as seeds for Munc18-1WT polymerization but 
were unable to trigger α-Syn aggregation in vitro, ruling out 
self-propagating activity of Munc18-1C180Y polymers on α-Syn. 
Indeed, it would have been surprising to template the polym-
erization of a protein that is so structurally dissimilar. Our re-
sults also revealed that a high level of selectivity is required 
in the coaggregation, with known binders of Munc18-1 such 
as syntaxin1A (unpublished data) and SNAP25 excluded from 
the aggregates. Moreover, another protein with known aggre-
gative properties, SOD1, did not coaggregate with Munc18-1 
EIEE4-causing mutants, which strongly suggests some level of 
specificity for Munc18-1 binding to α-Syn.
Munc18-1 acts as a chaperone for α-Syn 
and controls its aggregative propensity
Munc18-1 human mutations are responsible for generating the 
strong epileptic phenotype observed in EIEE4 patients (Otsuka 
et al., 2010; Saitsu et al., 2010). Our data strongly suggest that 
the Munc18-1C180Y mutation can cause protein misfolding, as 
well as a specific aggregation that recruits both endogenous 
Munc18-1 and α-Syn. This indicates a possible pathogenic gain 
of function. However, EIEE4-causing genetic alterations also 
include partial or full deletion of the Munc18-1 gene, suggest-
ing that haploinsufficiency itself should be sufficient to promote 
an aggregative phenotype that leads to the pathology. Our re-
sults reveal that knocking out Munc18-1 in neurosecretory 
cells (MKO-PC12 cells) is sufficient to significantly increase 
the number of endogenous and expressed α-Syn aggregates, an 
effect that can be fully rescued by reexpression of Munc18-1WT 
in these cells. This suggests that Munc18-1 plays a key role in 
chaperoning α-Syn and that Munc18-1 haploinsufficiency is 
sufficient to promote the aggregative phenotype.
A molecular chaperone is defined as a protein that controls 
the folding or unfolding and the assembly or disassembly of 
other proteins. One major function of chaperones is to prevent 
proteins and assembled protein complexes from aggregating 
(Kim et al., 2013; Saibil, 2013). The evidence provided by our 
study fits with this definition, as we demonstrate that Munc18-1 
controls the aggregative propensity of α-Syn. We have found 
that EIEE-causing mutations of Munc18-1 coaggregate α-Syn 
both in vitro and when expressed in neurons and gene-edited 
neurosecretory cells. We also demonstrate that expression of 
these mutants can effectively recruit endogenous α-Syn into ag-
gregates in neurons and gene-edited neurosecretory cells. Con-
versely, we have shown that expression of a PD-linked α-Syn 
mutant causes endogenous and expressed Munc18-1WT to co-
aggregate with α-Syn. Finally, we have revealed that knocking 
out Munc18-1 increases the propensity of α-Syn to aggregate, 
a phenotype that can be fully rescued by Munc18-1 reexpres-
sion in a concentration-dependent manner. Together, these 
lines of evidence point to a critical role of Munc18-1 in pre-
venting α-Syn aggregation and therefore fit with the definition 
of a chaperone. It is likely that Munc18-1 directly controls the 
aggregation of α-Syn, as we demonstrate that it directly binds 
to both endogenous and expressed α-Syn and that this binding 
is potentiated by EIEE4 mutations. Our findings therefore re-
veal that Munc18-1 is a molecular chaperone for α-Syn. This 
is not unexpected, as Munc18-1 is already known to chaperone 
Figure 6. Munc18-1 EIEE4-causing muta-
tions recruit endogenous α-Syn in MKO-PC12 
cells. (A) MKO-PC12 cells were transfected 
with EIEE4-causing Munc18-1 mutants, fixed, 
and immunolabeled with anti–α-Syn antibody. 
Representative images of MKO-PC12 cells ex-
pressing EIEE4-causing Munc18-1 mutants and 
probed with endogenous α-Syn. Bar, 20 µm. 
Arrowheads indicate colocalized aggregates. 
(B) Percentage of colocalized aggregates per 
MKO-PC12 cell. (C) Percentage of MKO-PC12 
cells containing aggregates. Data represent 
mean ± SEM. 10–20 cells were analyzed for 
each independent experiment (n = 3).
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syntaxin1A (Pevsner et al., 1994; Misura et al., 2000; Malintan 
et al., 2009; Han et al., 2011), and the aggregative property of 
α-Syn can be reduced by the expression of molecular chaper-
ones such as Hsp70 (Auluck et al., 2002; Maries et al., 2003; 
Cantuti-Castelvetri et al., 2005).
In summary, our results point to a critical role for Munc18-1 
in reducing the formation of toxic α-Syn oligomers by chap-
eroning α-Syn, thereby controlling its aggregative propensity. 
Considering that α-Syn was recently shown to have a prion-like 
activity (Prusiner et al., 2015) and that Munc18-1 knockout 
mice show clear evidence of neurodegeneration (Law et al., 
2016), uncovering the nature of the Munc18-1 binding site for 
α-Syn could have significant therapeutic value and potentially 
disease-modifying consequences for a number of neurodegener-
ative diseases, including PD, EIEE, and multiple system atrophy.
Materials and methods
Preparation of Leishmania tarentolae extract
L. tarentolae cell-free lysate was produced as described by previously 
(Mureev et al., 2009; Kovtun et al., 2011; Johnston and Alexandrov, 
2014). In brief, L. tarentolae parrot strain was obtained as LEX SY host 
P10 from Jena Bioscience and cultured in TBGG medium containing 
0.2% vol/vol penicillin/streptomycin (Thermo Fisher Scientific) and 
0.05% wt/vol Hemin (MP Biomedicals). Cells were harvested by cen-
trifugation at 2,500 g; washed twice by resuspension in 45 mM Hepes, 
pH 7.6, containing 250 mM sucrose, 100 mM potassium acetate, and 
3 mM magnesium acetate; and resuspended to 0.25 g cells per gram 
suspension. Cells were placed in a cell disruption vessel (Parr Instru-
ments) and incubated under 7,000-KPa nitrogen for 45 min, and then 
lysed by rapid release of pressure. The lysate was clarified by sequential 
centrifugation at 10,000 and 30,000 g and antisplice leader DNA leader 
oligonucleotide was added to 10  µM. The lysate was then desalted 
into 45 mM Hepes, pH 7.6, containing 100 mM potassium acetate and 
3 mM magnesium acetate, supplemented with a coupled translation/
transcription feeding solution, and then snap-frozen until required.
Gateway plasmids for cell-free protein expression
The proteins were cloned into the following cell-free expression Gate-
way destination vectors: N-terminal GFP tagged (pCellFree_G03), 
C-terminal sGFP tagged (pCellFree_G04), or C-terminal mCherry- 
cMyc tagged (pCellFree_G08; Gagoski et al., 2015). Transfer of ORFs 
between vectors was carried using Gateway PCR cloning protocol 
based on insert amplification with primers to attB1 and attB2 sites (for-
ward primer: 5′-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT-3′ 
[nnn] 18–25; reverse primer: [nnnn] 5′-18-25AAC CCA GCT TTC TTG 
TAC AAA GTG GTC CCC-3′; Walhout et al., 2000).
Figure 7. Munc18-1C180Y mutation recruits endogenous α-Syn 
aggregation and forms Lewy body–like structures. Hippocampal 
neurons were transfected with Munc18-1WT-emGFP and Munc18-
1C180Y-emGFP and immunolabeled with anti–α-Syn antibody. 
(A) Representative images of hippocampal neurons expressing 
Munc18-1C180Y and probed for endogenous α-Syn. Bars: 20 µm; 
(magnified images) 5 µm. Arrowhead indicates colocalized ag-
gregates. 11 neurons were analyzed per experiment (n = 3 inde-
pendent experiment, so a total of 33 neurons were examined). 
(B) Relative frequency distribution of the size of Lewy body–like 
structures. (C) Representative correlative fluorescence electron mi-
crograph of a Munc18-1C180Y–positive aggregate in MKO-PC12 
cells. Bars: (left) 5 µm; (center) 2 µm; (right) 500 nm. Arrowheads 
indicate cellular aggregates. (D) Representative images of hip-
pocampal neurons transfected with either Munc18-1WT-emGFP 
or Munc18-1C180Y-emGFP. Nuclei were stained with DAPI. Bars, 
10 µm. Arrowhead indicates a spheroid and arrow indicates 
pyknotic nucleus. (E) Percentage of pyknotic nuclei analyzed 
from Munc18-1WT-emGFP (control) and Munc18-1C180Y-emGFP 
transfected neurons. Data represent mean ± SEM (n = 6 regions 
of interest containing 7–12 transfected neurons each; ***, P < 
0.001, unpaired Student’s t test).
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Cell-free protein expression
Cell-free expression of proteins for interaction mapping used the eu-
karyotic L. tarentolae cell-free system. DNA templates for the various 
ORFs used the Gateway cloning system, with ribosome engagement 
with T7 transcribed mRNA mediated by the species-independent 
translation initiation site (Mureev et al., 2009). α-Syn was tagged 
with the genetically encoded fluorophores at the C terminus, as N 
terminus tagging prevents their natural oligomerization and aggrega-
tion. Coupled transcription/translation occurred for 3  h at 27°C un-
less otherwise described.
Single-molecule spectroscopy
Single-molecule spectroscopy was performed based on previous stud-
ies (Gambin et al., 2009, 2011; Martin et al., 2014). 20 µl of samples 
was used for each experiment and placed into a custom-made silicone 
192-well plate equipped with a glass coverslip (ProSciTech Australia). 
Plates were analyzed on an LSM710 microscope (ZEI SS) with a con-
focor3 module at room temperature. Two lasers (488 nm and 561 nm) 
were cofocused in solution using a 40× 1.2 NA water-immersion ob-
jective (ZEI SS); fluorescence was collected and split into the GFP and 
mCherry channels by a 560-nm dichroic mirror. The GFP emission was 
further filtered by a 505- to 540-nm band-pass filter and the mCherry 
emission was filtered using a 580-nm long-pass filter.
The single-molecule multicolor detection method is based on a 
simple principle: the two excitation lasers are focused within the same 
point, creating a very small observation volume (∼1 fl). The proteins 
are tagged with genetically encoded GFP and mCherry fluorophores. 
Proteins diffuse freely by Brownian motion, and they enter and exit the 
confocal volume constantly.
The mean intensity was calculated for both mCherry (<Ic(t)>) 
and GFP traces (<IG(t)>). The time traces were acquired with 1-ms time 
“bins,” and the large events were relatively rare, ensuring that the mean 
value correctly approximates the background of monomeric proteins.
The aggregates were detected as intense bursts of fluorescence, 
where the number of photons acquired in 1 ms were significantly 
higher than the mean value. We found that a “threshold” of 1,500 pho-
tons above the mean signal values efficiently separates the fluctuations 
of background and the high-amplitude bursts of the aggregates. Note 
that 1,500 photons correspond approximately to the simultaneous dif-
fusion of 30–50 proteins.
For each time bin where Ic(t) + IG(t) > 1,500 + (<Ic(t)> + <Ic(t)>), 
the incorporation of GFP-tagged proteins into the mCherry-tagged ag-
gregates was calculated as the ratio of mCherry signal to the total sig-
nal, after corrections of background:
  C =    
 (  I C ( t )​−​​< I C ( t ) > )   _______________________  
 (  I G ( t )​−​​< I G ( t ) > ) +  (  I C ( t )​−​​< I C ( t ) > )  . 
The histograms of distribution of C values can be interpreted in terms 
of proportions of GFP and mCherry in the oligomers: a GFP-only 
Figure 8. PD-linked α-Syn mutants coaggre-
gate Munc18-1WT and endogenous Munc18-1.  
(A) MKO-PC12 cells were cotransfected with 
either α-SynWT-GFP or indicated PD-linked 
α-Syn mutants and Munc18-1WT-mCherry. 
Representative images showing coaggre-
gates positive for PD-linked α-Syn mutants and 
Munc18-1WT-mCherry in MKO-PC12 cells. 
Bars, 20 µm. (B) Percentage of colocalized ag-
gregates. (C) Percentage of MKO-PC12 cells 
containing aggregates. 10–20 cells in each 
independent experiment were quantified. Data 
represent mean ± SEM; n = 5. (D) α-SynWT-GFP 
or PD-linked α-Syn mutants were transfected in 
PC12 cells and endogenous Munc18-1 was 
immunolabeled with anti–Munc18-1 antibody. 
Representative images showing coaggregates 
positive for GFP-tagged PD-linked α-Syn mu-
tants and endogenous Munc18-1 in PC12 
cells. Bars, 20 µm. Arrowheads indicate the 
colocalized aggregates. (E) Percentage of co-
localized aggregates. (F) Percentage of PC12 
cells containing aggregates. Data represent 
mean ± SEM. 10–20 cells were quantified in 
each independent experiment (n = 3).
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aggregate would appear at C = 0, whereas a mCherry-only burst would 
appear at C = 1.  When the two fluorophores are codetected, the C 
values represent a direct measure of stoichiometry of incorporation 
in the mixed aggregate.
As shown by the examples of individual bursts traces, we can 
easily detect whether the large aggregate contains the two fluorophores. 
The histograms are shown as an overall quantification of all large events.
Antibodies and reagents
Mouse anti-Sx1a (S0644; clone HPC-1) and mouse anti–β-actin 
(A5316; clone AC-74) were obtained from Sigma-Aldrich, and anti–
Munc18-1 (610336) was obtained from BD.
Mouse anti–α-Syn (27766) was obtained from Abcam. Mouse 
anti-VAMP2 (104211) was obtained from Synaptic Systems. PC12 
cells and MKO-PC12 cells were maintained as described previ-
ously (Martin et al., 2013).
Munc18-1 single guide RNA (sgRNA) expression construct
A 20-bp guide sequence (5′-ATT GGC CTC AAG GCG GTG GT-3′) 
targeting DNA within the first exon of Munc18-1 was selected from 
an online CRI SPR design tool. The sgRNA expression construction 
method has been described previously (Ran et al., 2013).
Transfection and cell sorting of MKO-PC12 cells
PC12 cells were cultured in six-well dishes to 70–80% confluence. 
Cells were transfected with 1 µg sequence-verified pSpCas9-Munc18-1 
(sgRNA)-2A-GFP using Lipofectamine 2000 (Invitrogen). 48  h 
after transfection, cells were pelleted in DMEM and sorted in 96-
well plates using a FAC SAris II cell sorter (BD). Single cells from 
GFP-expressing cells (high expression population) were expanded to 
obtain individual clones.
Clone validation
Individual clones were lysed with 1% Triton X-100 and centrifuged at 
14,000 rpm for 20 min at 4°C. The whole-cell lysates were eluted in 2× 
SDS sample buffer and analyzed by Western blot with specific antibody 
against Munc18-1. Genomic DNA was isolated from edited clones and 
nonedited PC12 cells (control). A region of exon1 of the Munc18-1 gene 
was amplified with genomic DNA specific primers (forward primer, 5′-
CGG AGT CCG CGC GTC AGT CGGT-3′; reverse primer, 5′-ATA AAG 
Figure 9. Munc18-1 controls endogenous 
α-Syn propensity to aggregate in vitro and in 
gene-edited neurosecretory cells. (A) Seeds 
of Munc18-1C180Y do not recruit α-Syn in 
vitro. A single-molecule trace obtained from 
seed experiments. α-Syn-GFP is not recruited 
to the seeds of Munc18-1C180Y-mCherry. (B) 
Histogram of single-molecule coincidence be-
tween α-Syn-GFP and seeds of Munc18-1C180Y-
mCherry. (C) A single-molecule trace obtained 
for cell-free lysates expressing α-SynA30P-GFP 
alone. (D) A single-molecule trace obtained 
for cell-free lysates coexpressing α-SynA30P-GFP 
and Munc18-1WT-mCherry (E) Detailed analy-
sis of the distribution of fluorescence bursts 
from C and D, showing a reduction in bright 
events caused by the chaperone activity 
of Munc18-1.  (F) Munc18-1WT-emGFP was 
transfected in MKO-PC12 cells, and FACS 
was applied to separate low-expressing from 
high-expressing Munc18-1 WT-emGFP trans-
fected MKO-PC12 cells. MKO-PC12 cells to-
gether with control PC12 cells were platted 
for 4 h, fixed, and immunolabeled for α-Syn. 
Representative image of endogenous α-Syn 
from indicated cells. Bars, 20 µm. (G) FACS 
forward scatterplot showing gates used to se-
lect cells with half and full expression levels 
of Munc18-1WT-emGFP (H) The area occupied 
by endogenous α-Syn was quantified and the 
frequency distribution plotted. (I) The number 
of aggregates per cell and the percentage of 
cells containing aggregates were measured 
in PC12 cells and Munc18-1WT-emGFP low- 
to higher-expressing MKO-PC12 cells. Data 
represent mean ± SEM. 10–20 cells for each 
independent experiment were quantified (n = 
3). One-way ANO VA was performed (**, P 
< 0.01; *** P < 0.001; n.s, not significant).
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GGG CGG ATG GGG GAG GGA-3′). The PCR products were A-tailed 
and cloned into pGEM-T easy (Promega) and sequenced in the Austra-
lian Genome Research Facility, University of Queensland.
Cell transfection and neuronal culture
PC12 cells and MKO-PC12 cells were cotransfected with Munc18-1 
and α-Syn constructs using Lipofectamine LTX (Invitrogen) accord-
ing to the manufacturer’s instruction and expressed 24–48 h before 
replating onto poly-d-lysine–coated glass-bottomed MatTek Corpora-
tion dishes or coverslips. Hippocampal rat neurons from E18 Sprague–
Dawley rat pups were plated onto poly-l-lysine–coated dishes in 
Neurobasal growth medium supplemented with 2% B27 and 2 mM 
Glutamax. Neurons were switched to serum-free Neurobasal medium 
24 h after seeding and medium was replaced twice per week. Transient 
transfection of hippocampal neurons was performed at 8–10 d in vitro 
using Lipofectamine 2000 (Invitrogen), and the cells were imaged 48 h 
after transfection. Approval for animal studies was obtained from the 
University of Queensland Animal Ethics Committee.
Immunofluorescence microscopy
PC12 cells and MKO-PC12 cells or hippocampal neurons were cotrans-
fected with Munc18-1 and α-Syn constructs. Quantitative immunoflu-
orescence was performed by collecting images with a 63× 1.40 NA 
oil-immersion objective on an LSM510 confocal microscope (ZEI SS). 
The colocalization of aggregates was analyzed by a surface tool in 
Imaris (Bitplane). Munc18-1C180Y-GFP aggregates were identified 
using a threshold background subtraction combining a minimum object 
size of 0.46 µm and minimum intensity of 19.2. We then compared the 
total number of Munc18-1C180Y aggregates detected with the number of 
Munc18-1C180Y aggregates that colocalized with α-Syn aggregates and 
expressed the result as percentage.
Immunoprecipitation and Western blotting
PC12 cells were transfected with the Munc18-1 constructs. The whole-
cell lysates of Triton X-100 extracts were centrifuged at 14,000 rpm 
for 20 min at 4°C and cleared with protein A or G Sepharose over-
night at 4°C, followed by four washes with ice-cold lysis buffer (1% 
Triton X-100, 1 mM EDTA, 1 mM EGTA, and complete EDTA-free 
protease inhibitor cocktails; Roche). Precleared lysates were then in-
cubated with anti-GFP antibodies coupled to protein A or G Sepharose 
overnight at 4°C, followed by four washes with ice-cold lysis buffer 
and elution in 2× SDS sample buffer. The immunoprecipitated proteins 
were resolved by SDS-PAGE and probed by Western blot analysis with 
antibodies against Munc18-1, α-Syn, and β-actin.
NPY-hPLAP release assay
WT PC12 cells or MKO-PC12 cells were transfected with NPY-hPLAP 
plasmid and the indicated Munc18-1 for 48 h. Cells were washed and 
incubated with PSS buffer as a control (145 mM NaCl, 5.6 mM KCl, 
0.5 mM MgCl2, 5.6 mM glucose, and 15 mM Hepes-NaOH, pH 7.4) or 
stimulated with high K+-PSS buffer (81 mM NaCl, 70 mM KCl, 2.2 mM 
CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM Hepes-NaOH, pH 
7.4) for 15 min at 37°C, and supernatants were collected. After col-
lecting the supernatants, cells were lysed with 0.2% Triton X-100 to 
measure total NPY-hPLAP. The released and total NPY-hPLAP was 
measured using the chemiluminescent reporter gene assay system 
(Phospha-Light; Applied Biosystems) according to the manufacturer’s 
instructions, and the results were expressed as a percentage of total 
NPY-hPLAP (Tomatis et al., 2013).
Figure 10. Munc18-1WT reexpression in MKO-PC12 cells rescues the 
propensity α-SynWT and two PD-linked α-Syn mutants to aggregate. 
α-SynWT-GFP or PD-linked α-Syn mutants were transfected in PC12 cells 
or MKO-PC12 cells (top and middle). α-SynWT-GFP and Munc18-1WT–
mCherry or PD-linked α-Syn mutants and Munc18-1WT-mCherry were 
cotransfected in MKO-PC12 cells to rescue the Munc18-1WT expression 
(bottom). (A) Representative images of aggregates positive for α-SynWT and 
PD-linked α-Syn mutants in PC12 cells (top) or in MKO-PC12 cells (middle), 
and MKO-PC12 cells expressing Munc18-1WT-mCherry (bottom). Bar, 20 
µm. Arrowheads indicate the colocalized aggregates. The number of ag-
gregates per cell (B) and the percentage of cells containing aggregates 
(C) were quantified. Data represent mean ± SEM. 10–20 cells for each 
independent experiment were quantified (n = 3; *, P < 0.05; **, P < 0.01; 
***, P < 0.001; one way ANO VA).
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Statistical analyses
All experiments were repeated at least three times. Data analysis 
was performed using unpaired, Student’s t tests or one-way analy-
sis of variance (ANO VA) followed by multiple comparisons test as 
stated in the figures. Data were considered significant at P < 0.05. 
Values are expressed as means ± SEM, and the level of significance 
is designated in the figure legend as follows: *, P < 0.05; **, P 
< 0.01; ***, P < 0.001.
Online supplemental material
Fig. S1 shows functional validation of MKO-PC12 cells and rescue 
of Munc18-1 expression levels. Fig. S2 shows the Munc18-1C180Y 
mutant coaggregates with Munc18-1WT in MKO-PC12 cells and 
hippocampal neurons. Fig. S3 shows Munc18-1C180Y mutants 
cause Lewy body–like structures positive for Munc18-1WT and 
α-Syn. Fig. S4 shows PD-linked α-Syn mutants form Mun18-1WT 
and endogenous Munc18-1-positive Lewy body–like structures. Fig. 
S5 shows endogenous Munc18-1 interacts with endogenous α-Syn 
in cortical neurons and PC12 cells. Online supplemental material is 
available at http ://www .jcb .org /cgi /content /full /jcb .201512016 /DC1. 
Additional data are available in the JCB DataViewer at http ://dx .doi 
.org /10 .1083 /jcb .201512016 .dv.
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